Analysis of Transplantation Rate and Overall Treatment Efficacy by Age for Patients Aged 60 to 75 with Untreated Secondary Acute Myeloid Leukemia (AML) Given CPX-351 Liposome Injection Versus Conventional Cytarabine and Daunorubicin in a Phase III Trial
Lancet, Jeffery, Uy, Geoffrey L., Cortes, Jorge, Newell, Laura F., Lin, Tara L., Ritchie, Ellen, Stuart, Robert, Strickland, Stephen, Hogge, Donna, Solomon, Scott R., Stone, Richard M., Bixby, Dale L.Volume:
23
Language:
english
Journal:
Biology of Blood and Marrow Transplantation
DOI:
10.1016/j.bbmt.2016.12.090
Date:
March, 2017
File:
PDF, 261 KB
english, 2017